These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Drug resistance of HIV-1 as a result of using nevirapine for chemoprophylaxis of vertical viral transmission from HIV-infected mother to infant]. Kazennova EV Vopr Virusol; 2009; 54(1):45-8. PubMed ID: 19253732 [TBL] [Abstract][Full Text] [Related]
10. The controversies of nevirapine for preventing mother-to-child HIV transmission. Smith DM AIDS; 2006 Jan; 20(2):281-3. PubMed ID: 16511423 [No Abstract] [Full Text] [Related]
11. This is no time to stop use of nevarapine to prevent mother-to-child transmission of HIV. Oleske JM AIDS; 2006 Apr; 20(7):1059-60. PubMed ID: 16603859 [No Abstract] [Full Text] [Related]
16. Preventing mother-to-infant transmission of HIV in the developing world. Laurence J AIDS Read; 1999 Oct; 9(7):448-9, 496. PubMed ID: 12737134 [No Abstract] [Full Text] [Related]
17. Mother-to-child transmission of HIV-1 infection. Montgomery E; Wells J; Strani L Lancet; 2002 Aug; 360(9333):643-4. PubMed ID: 12241959 [No Abstract] [Full Text] [Related]
18. Risk of archived resistance after intrapartum nevirapine. S Afr Med J; 2004 May; 94(5):334-5. PubMed ID: 15211942 [No Abstract] [Full Text] [Related]
19. Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS. Coovadia H N Engl J Med; 2004 Jul; 351(3):289-92. PubMed ID: 15247337 [No Abstract] [Full Text] [Related]